tert-Butyl (5R)-5-hydroxy-3,3-dimethylpiperidine-1-carboxylate, 98%, 250mg

(1-(Tetrahydro-2H-pyran-2-yl)-1H-pyrazol-4-yl)methanamine, 95%, 250mg

(1S,2S)-2-Aminocyclopentanecarboxylic acid, 95.0%, 5g

9,10-Dibromo-2-phenylanthracene>98.0%(GC)1g

Uridina, mínimo 99 %, para bioquímica, 5 g, envase de plástico.

(3R,5R)-1-(tert-Butylsulfonyl)-5-(2,5-difluorophenyl)pyrrolidin-3-ol, 98%, 1g

Tetraisopropylthiuram Disulfide>98.0%(N)25g

METHYL 4,5,6,7-TETRAHYDRO-4-OXOPYRAZOLO[1,5-A]PYRAZINE-2-CARBOXYLATE, 95.0%, 5g

trans,trans-4-(3,4-Difluorophenyl)-4'-ethyl-1,1'-bi(cyclohexane), 97%, 100g

N'-((Dimethylamino)methylene)-N,N-dimethylformohydrazonamide dihydrochloride, 90.0%, 5g

(3aS,4R,6S,7R,7aR)-4-(Hydroxymethyl)-6-(4-methoxyphenoxy)-2,2-dimethyltetrahydro-4H-[1,3]dioxolo[4,5-c]pyran-7-ol, 97%, 5g

Vaso de precipitados ROTILABO® forma baja, 950 ml, 1 pieza

sol estándar de n-alcano (C10-C40), 16 componentes (cada uno de 50 mg/l) en n-hexano, 5 ml